☰

Ghiabe H. Guibinga, Ph.D. - Publications

Affiliations: 
2001 McGill University, Montreal, QC, Canada 
Area:
Cell Biology, Pathology
Tree Info Grants Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Guibinga GH, Sahay B, Brown H, Cooch N, Chen J, Yan J, Reed C, Mishra M, Yung B, Pugh H, Schultheis K, Esquivel RN, Weiner DB, Humeau LH, Broderick KE, et al. Protection against infection mediated by a synthetically engineered DNA vaccine. Human Vaccines & Immunotherapeutics. 1-9. PMID 32783701 DOI: 10.1080/21645515.2020.1789408  0.323
2019 Esquivel RN, Patel A, Kudchodkar SB, Park DH, Stettler K, Beltramello M, Allen JW, Mendoza J, Ramos S, Choi H, Borole P, Asija K, Bah M, Shaheen S, Chen J, ... ... Guibinga G, et al. In Vivo Delivery of a DNA-Encoded Monoclonal Antibody Protects Non-human Primates against Zika Virus. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 30962164 DOI: 10.1016/J.Ymthe.2019.03.005  0.333
2005 Waheed I, Gilbert R, Nalbantoglu J, Guibinga GH, Petrof BJ, Karpati G. Factors associated with induced chronic inflammation in mdx skeletal muscle cause posttranslational stabilization and augmentation of extrasynaptic sarcolemmal utrophin. Human Gene Therapy. 16: 489-501. PMID 15871680 DOI: 10.1089/Hum.2005.16.489  0.616
2004 Matecki S, Guibinga GH, Petrof BJ. Regenerative capacity of the dystrophic (mdx) diaphragm after induced injury. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 287: R961-8. PMID 15191902 DOI: 10.1152/Ajpregu.00146.2004  0.613
2001 Guibinga GH, Ebihara S, Nalbantoglu J, Holland P, Karpati G, Petrof BJ. Forced myofiber regeneration promotes dystrophin gene transfer and improved muscle function despite advanced disease in old dystrophic mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 4: 499-507. PMID 11708887 DOI: 10.1006/Mthe.2001.0482  0.639
2000 Ebihara S, Guibinga GH, Gilbert R, Nalbantoglu J, Massie B, Karpati G, Petrof BJ. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice. Physiological Genomics. 3: 133-44. PMID 11015608 DOI: 10.1152/Physiolgenomics.2000.3.3.133  0.674
1999 Gilbert R, Nalbantoglu J, Petrof BJ, Ebihara S, Guibinga GH, Tinsley JM, Kamen A, Massie B, Davies KE, Karpati G. Adenovirus-mediated utrophin gene transfer mitigates the dystrophic phenotype of mdx mouse muscles. Human Gene Therapy. 10: 1299-310. PMID 10365661 DOI: 10.1089/10430349950017987  0.656
1998 Guibinga GH, Lochmuller H, Massie B, Nalbantoglu J, Karpati G, Petrof BJ. Combinatorial blockade of calcineurin and CD28 signaling facilitates primary and secondary therapeutic gene transfer by adenovirus vectors in dystrophic (mdx) mouse muscles. Journal of Virology. 72: 4601-9. PMID 9573223 DOI: 10.1128/Jvi.72.6.4601-4609.1998  0.565
Show low-probability matches.